Vivos Therapeutics, Inc.
VVOS—
Vivos Therapeutics, Inc.VVOS$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-2.07
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$17.44M
Net income
$-21.17M
Net margin
-121.4%
Gross margin
60.4%
Dividends & financials
Vivos Therapeutics, Inc. (VVOS) reported revenue of $17.44M and net income of $-21.17M, or $-2.07 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.